Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, Retatrutide reduces hunger pangs, {promotesglucose regulation, and ultimately results in significant reduction in body mass.… Read More